Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of doxycycline + tauroursodeoxycholic acid versus supportive therapy in transthyretin cardiac amyloidosis
2017-001621-41Phase 3Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of doxycycline and tauroursodeoxycholic acid in amyloid cardiomyopathy (2 arms), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Major cardiac events. Started Nov 2020; status: completed.
02
Drugs
doxycyclinetauroursodeoxycholic acid
03
Conditions
amyloid cardiomyopathy
Beyond the preview
Go deeper on 2017-001621-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001621-41.